Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance)
- Citation:
- Clin Cancer Res vol 21 (5) 1078-1086
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 4
- Parents:
- 995
- Children:
- None
- Pharmas:
- Grants:
- U10 CA047577, U10 CA032291, CA33601, CA47577, U10 CA086726, U10 CA045564, P30 DK026743, U10 CA045808, U10 CA031946, U10 CA033601, U10 CA045389, CA60138, U10 CA180821, U10 CA077597, U10 CA059518, U10CA180882, U10 CA077440, U10 CA041287, U10 CA047559, U10 CA180882, U10 CA074811, U10CA180821, CA31946, U10 CA003927
- Corr. Author:
- Authors:
- Stephanie M. Cushman Chen Jiang Ace J. Hatch Ivo Shterev Alexander B. Sibley Donna Niedzwiecki Alan P. Venook Kouros Owzar Herbert I. Hurwitz Andrew B. Nixon
- Networks:
- CA136, LAPS-MA036, LAPS-NC010
- Study
- CALGB-80203
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Article